玻璃体切除联合内界膜剥除术治疗糖尿病性黄斑水肿临床疗效的Meta分析
Meta-Analysis of the Clinical Efficacy of Vitrectomy Combined with Internal Limiting Membrane Peeling in the Treatment of Diabetic Macular Edema
DOI: 10.12677/acm.2024.14112998, PDF,   
作者: 邰仁清, 葛 瑶:山东第二医科大学临床医学院,山东 潍坊;高宏程, 陈 晨*:临沂市人民医院眼科,山东 临沂
关键词: 玻璃体切除术内界膜剥除术糖尿病性黄斑水肿Meta分析Vitrectomy Inner Limiting Membrane Peeling Diabetic Macular Edema Meta-Analysis
摘要: 目的:运用Meta方法评价玻璃体切除(PPV)联合内界膜剥除术(ILMP)治疗糖尿病性黄斑水肿(DME)临床疗效。方法:检索自从建库以来至2022年12月的维普中文期刊数据库(VIP)、中国生物医学文献数据库(CBM)、万方数据库(Wanfang Data)、中国知网(CNKI)、PubMed、Embase、Cochrane、等相关文献,搜集PPV联合ILMP治疗DME的临床随机对照试验(RCT)的相关文献研究,使用RevMan5.4、Stata17.0等软件对纳入文献的相关数据进行统计学分析。结果:本研究纳入7项文献,合计431只眼。Meta分析结果表明,1) 最佳矫正视力(BCVA):术后1个月(MD = −0.26, 95%CI [−0.37, −0.14], z = 4.30, P < 0.0001)、3个月(MD = −0.13, 95%CI [−0.21, −0.04], z = 2.94, P = 0.003 < 0.05)、6个月(MD = −0.11, 95%CI [−0.16, −0.06], z = 4.22, P < 0.0001)、12个月(MD = −0.08, 95%CI [−0.13, −0.03], z = 3.36, P = 0.0008 < 0.05)的BCVA的平均变化均可证明玻璃体切除术联合内界膜剥除术在提高最佳矫正视力方面明显优于单纯玻璃体切除术。2) 视网膜中央厚度(CMT):术后3个月(MD = −47.11, 95%CI [−50.69, −43.53], z = 25.77, P < 0.00001)、6个月(MD = −53.62, 95%CI [−100.78, −6.45], z = 2.23, P = 0.03 < 0.05)的CMT的平均变化均可证明玻璃体切除术联合内界膜剥除术在改善视网膜中央厚度方面明显优于单纯玻璃体切除术。结论:PPV联合ILMP治疗DME的临床疗效明显优于单纯PPV。
Abstract: Objective: To evaluate the clinical efficacy of vitrectomy combined with inner limiting membrane peeling (ILMP) in the treatment of diabetic macular edema (DME). Methods: Relevant articles were searched from VIP, CBM, Wanfang Data, CNKI, PubMed, Embase, Cochrane Library and other databases from the establishment of the database to December 2022. The relevant literatures of randomized controlled trials (RCTS) of PPV combined with ILMP in the treatment of DME were collected. Stata17.0 and RevMan5.4 software were used for Meta-analysis of the inclusion study. Results: A total of 7 RCTS were included in the experiment with a total of 431 eyes. The results of Meta-analysis showed that 1) Best corrected visual acuity (BCVA): The mean changes in BCVA at 1 month (MD = −0.26, 95%CI [−0.37, −0.14], z = 4.30, P < 0.0001), 3 months (MD = −0.13, 95%CI [−0.21, −0.04], z = 2.94, P = 0.003 < 0.05), 6 months (MD = −0.11, 95%CI [−0.16, −0.06], z = 4.22, P < 0.0001) and 12 months (MD = −0.08, 95%CI [−0.13, −0.03], z = 3.36, P = 0.0008 < 0.05) after surgery can prove that compared with vitrectomy alone, vitrectomy combined with internal limiting membrane peeling could significantly improve best corrected visual acuity. 2) Central retinal thickness (CMT): Mean changes in CMT at 6 months (MD = −53.62, 95%CI [−100.78, −6.45], z = 2.23, P = 0.03 < 0.05) and 3 months (MD = −47.11, 95%CI [−50.69, −43.53], z = 25.77, P < 0.00001) after surgery can prove that compared with vitrectomy alone, vitrectomy combined with internal limiting membrane peeling could significantly lower central retinal thickness. Conclusions: PPV combined with ILMP in the treatment of DME is better than PPV alone.
文章引用:邰仁清, 葛瑶, 高宏程, 陈晨. 玻璃体切除联合内界膜剥除术治疗糖尿病性黄斑水肿临床疗效的Meta分析[J]. 临床医学进展, 2024, 14(11): 1170-1179. https://doi.org/10.12677/acm.2024.14112998

参考文献

[1] 王广慧, 李光达, 李军, 等. 玻璃体切割术中联合内界膜剥除治疗糖尿病性黄斑水肿[J]. 临床眼科杂志, 2008, 16(5): 416-417.
[2] 朱婷婷, 王权, 姜彩辉. 糖尿病黄斑水肿治疗新进展[J]. 眼科新进展, 2019, 39(3): 296-300.
[3] 刘哲丽, 孙鹏. 视网膜内界膜剥离治疗糖尿病黄斑水肿的疗效观察[J]. 中华眼底病杂志, 2005, 21(3): 138-141.
[4] Cumpston, M., Li, T., Page, M.J., Chandler, J., Welch, V.A., Higgins, J.P., et al. (2019) Updated Guidance for Trusted Systematic Reviews: A New Edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database of Systematic Reviews, 2019, Article No. ED000142. [Google Scholar] [CrossRef] [PubMed]
[5] 刘新玲, 白洁羽, 李彦昭. 玻璃体切割术联合或不联合内界膜剥除治疗严重增殖型糖尿病黄斑水肿的疗效对比[J]. 长寿, 2022(3): 61-63.
[6] 李秀娟, 关微. 内界膜剥除治疗顽固性糖尿病黄斑水肿的观察[J]. 中华眼外伤职业眼病杂志, 2018, 40(2): 85-88.
[7] 胡红霞, 侯立亭, 郭洋. 手术对增殖型糖尿病视网膜黄斑水肿的治疗效果[J]. 深圳中西医结合杂志, 2020, 30(11): 23-24.
[8] 林涛, 田楠楠. 益气养阴化瘀利水汤联合玻璃体切割+内界膜剥离手术治疗PDR合并黄斑水肿的疗效观察[J]. 中国中医眼科杂志, 2021, 31(3): 174-178.
[9] Ahmet, A., Fatih, A., Selen, K.H., et al. (2021) Benefit of Vitrectomy and Internal Limiting Membrane Peeling in the Treatment of Resistant Diabetic Macular Edema.
[10] Bahadır, M., Ertan, A. and Mertoğlu, Ö. (2006) Visual Acuity Comparison of Vitrectomy with and without Internal Limiting Membrane Removal in the Treatment of Diabetic Macular Edema. International Ophthalmology, 26, 3-8. [Google Scholar] [CrossRef] [PubMed]
[11] Hoerauf, H., Brüggemann, A., Muecke, M., Lüke, J., Müller, M., Stefánsson, E., et al. (2011) Pars Plana Vitrectomy for Diabetic Macular Edema. Internal Limiting Membrane Delamination vs Posterior Hyaloid Removal. a Prospective Randomized Trial. Graefes Archive for Clinical and Experimental Ophthalmology, 249, 997-1008. [Google Scholar] [CrossRef] [PubMed]
[12] 辛晓蓉, 巩天祥. 糖尿病视网膜表面膜细胞成分的研究[J]. 眼科新进展, 2013, 33(4): 309-311+315.
[13] Navarrete-Sanchis, J., Zarco-Bosquets, J., et al. (2015) Long-Term Effectiveness of Vitrectomy in Diabetic Cystoid Macular Edema. Graefes Archive for Clinical and Experimental Ophthalmology, 253, 713-719.
[14] Stefánsson, E. (2006) Ocular Oxygenation and the Treatment of Diabetic Retinopathy. Survey of Ophthalmology, 51, 364-380. [Google Scholar] [CrossRef] [PubMed]